US20050065474A1 - Catheter assembly - Google Patents
Catheter assembly Download PDFInfo
- Publication number
- US20050065474A1 US20050065474A1 US10/979,233 US97923304A US2005065474A1 US 20050065474 A1 US20050065474 A1 US 20050065474A1 US 97923304 A US97923304 A US 97923304A US 2005065474 A1 US2005065474 A1 US 2005065474A1
- Authority
- US
- United States
- Prior art keywords
- elongate member
- elongate shaft
- catheter
- spacer
- catheter system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0089—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
Definitions
- the present invention relates generally to intravascular catheters for performing medical procedures. More particularly, the present invention relates to shaft assemblies for use in intravascular catheters. Still, more particularly, the present invention relates to catheter shaft assemblies for use in injection catheters.
- Intravascular catheters are currently utilized in a wide variety of minimally invasive or percutaneous medical procedures.
- an intravascular catheter enables a physician to remotely perform a medical procedure by inserting the catheter into the vascular system of the patient at an easily accessible location and navigating the tip of the catheter to a desirable target site.
- a physician to remotely perform a medical procedure by inserting the catheter into the vascular system of the patient at an easily accessible location and navigating the tip of the catheter to a desirable target site.
- virtually any target site in the patient's vascular system may be remotely accessed.
- a percutaneous procedure begins with the step of inserting a distal portion of the catheter into the patient's vasculature at a convenient location.
- the physician may urge the distal tip forward by applying longitudinal forces to the proximal portion of the catheter.
- the path taken by a catheter through the vascular system is tortuous, requiring the catheter to change direction frequently.
- the physician While advancing the catheter through the tortuous path of the patient's vasculature, the physician must steer the distal end of the catheter.
- the physician typically is not able to manipulate the distal portion of the catheter directly. For this reason, physicians typically must steer the distal end of the catheter by applying torsional forces to the proximal portion of the catheter.
- Injection catheters are a type of catheter which may be used to inject therapeutic or diagnostic agents into various target tissues within the human body.
- An advantage of injection catheters is that the target tissue may be accessed utilizing minimally invasive surgical techniques. As with other types of catheters, the physician typically is not able to manipulate the distal portion of an injection catheter directly.
- the target tissue is within a wall of an organ such as the stomach or the heart.
- the target tissue is within the wall of an organ it is often desirable to inject the therapeutic or diagnostic agent into the tissue proximate the center of the organ wall. If the needle of the injection catheter inadvertently passes through the wall, the therapeutic or diagnostic agents dispensed from the distal end of the needle will not be effectively delivered to the target tissue.
- a medical procedure involving the delivery of a therapeutic and/or diagnostic agent to a targeted portion of a patient's body is the treatment of esophageal varices.
- This is a condition in which blood vessels of the esophagus are enlarged and may potentially burst.
- a therapeutic agent is injected into the varix.
- the agent may be a coagulant such as sodium morrhuate.
- An injection catheter may be used to deliver the therapeutic agent in order to minimize the invasive nature of the procedure.
- an injection catheter may be utilized in the treatment of ulcers in the stomach lining.
- an injection catheter may be used to deliver drugs such as sclerosing or vasoconstrictive agents. These drugs typically clot or occlude the bleeding tissue to stop bleeding or to reduce the possibility of a blood vessel bursting.
- Injection catheters may also be used to inject therapeutic or diagnostic agents into the heart.
- agents delivered to the heart include genes, proteins, or drugs.
- 27 or 28 gauge needles are generally used to inject solutions carrying genes, proteins, or drugs directly into the myocardium.
- a typical volume of an agent delivered to an injection site is about 100 microliters.
- Therapeutic and diagnostic agents may be delivered to a portion of the heart as part of a percutaneous myocardial revascularization (PMR) procedure.
- PMR percutaneous myocardial revascularization
- Assuring that the heart muscle is adequately supplied with oxygen is critical to sustaining the life of a patient.
- the heart muscle To receive an adequate supply of oxygen, the heart muscle must be well perfused with blood.
- blood perfusion is accomplished with a system of blood vessels and capillaries. However, it is common for the blood vessels to become occluded (blocked) or stenoic (narrowed).
- a stenosis may be formed by an atheroma, which is typically a harder, calcified substance which forms on the walls of a blood vessel.
- Coronary bypass surgery typically involves utilizing vascular tissue from another part of the patient's body to construct a shunt around the obstructed vessel.
- Angioplasty techniques such as percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) are relatively non-invasive methods of treating a stenotic lesion.
- PTA percutaneous transluminal angioplasty
- PTCA percutaneous transluminal coronary angioplasty
- These angioplasty techniques typically involve the use of a guidewire and a balloon catheter. In these procedures, a balloon catheter is advanced over a guidewire such that the balloon is positioned proximate a restriction in a diseased vessel.
- a third technique which may be used to treat a stenotic lesion is atherectomy. During an atherectomy procedure, the stenotic lesion is mechanically cut or abraded away from the blood vessel wall.
- Coronary by-pass, angioplasty, and atherectomy procedures have all been found effective in treating individual stenotic lesions in relatively large blood vessels.
- the heart muscle is perfused with blood through a network of small vessels and capillaries.
- a large number of stenotic lesions may occur in a large number of locations throughout this network of small blood vessels and capillaries.
- the tortuous path and small diameter of these blood vessels limit access to the stenotic lesions.
- the sheer number and small size of these stenotic lesions make techniques such as cardiovascular by-pass surgery, angioplasty, and atherectomy impractical.
- PMR percutaneous myocardial revascularization
- a PMR procedure generally involves the creation of holes, craters or channels directly into the myocardium of the heart. In a typical PMR procedure, these holes are created using radio frequency energy delivered by a catheter having one or more electrodes near its distal end. After the wound has been created, therapeutic agents are sometimes ejected into the heart chamber from the distal end of a catheter.
- PNM improves a patient's condition through denervation.
- Denervation is the elimination of nerves.
- the creation of wounds during a PMR procedure results in the elimination of nerve endings which were previously sending pain signals to the brain as a result of hibernating tissue.
- the present invention relates generally to intravascular catheters for performing medical procedures. More particularly, the present invention relates to shaft assemblies for use in intravascular catheters. Still, more particularly, the present invention relates to catheter shaft assemblies for use in injection catheters.
- This assembly may include a first elongate member having an internal lumen and a distal portion, a second elongate member, slidable within the first elongate member, and a spacer positioned between the second elongate member and the first elongate member.
- the spacer may be positioned at bendable portions of the first elongate member and the second elongate member such that the spacer maintains a substantially uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
- a shaft assembly in accordance with an exemplary embodiment of the present invention may also comprise a first elongate shaft having an inner surface defining a lumen, a second elongate shaft slidingly disposed within the lumen of the first elongate shaft, and an interstitial member disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate shaft.
- a plurality of longitudinal ribs extend beyond an inner surface of the first elongate shaft. These longitudinal ribs preferably contact the outer surface of the second elongate shaft.
- a radial rib extends beyond the inner surface of the first elongate shaft.
- the radial rib preferably contacts the outer surface of the second elongate shaft.
- An additional embodiment of a shaft assembly in accordance with the present invention includes a coil comprising a wire forming a plurality of turns. Each turn of the coil is disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate shaft.
- the second elongate shaft has a plurality of projections extending beyond the outer surface of the second elongate shaft. When the second elongate shaft is disposed within the lumen defined by the first elongate shaft, these projections preferably contact the inner surface of the first elongate shaft.
- An injection catheter in accordance with an exemplary embodiment of the present invention includes a first elongate shaft having an inner surface defining a lumen.
- a second elongate shaft having an outer surface is slidingly disposed within the lumen of the first elongate shaft.
- the second elongate shaft includes a point and an injection orifice proximate it's distal end.
- an interstitial member is disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate.
- a slider is fixed to the second elongate shaft proximate the proximal end thereof. Also in this embodiment, a portion of the slider is disposed within a cavity defined by a housing which is preferably fixed to the first elongate shaft proximate the proximal end thereof. Also in a preferred embodiment, a plurality of indicia are disposed on a face of the housing proximate the slider.
- a physician utilizing the catheter in a surgical procedure may move the distal end of the second elongate shaft a known distance relative to the distal end of the first elongate shaft. For example, a physician may urge the slider distally while visually observing the travel of the slider relative to the indicia of the housing. The movement of the slider is translated via the second elongate shaft to the distal end thereof.
- the presence of an interstitial member between the outer surface of the second elongate shaft and the inner surface of the first elongate shaft directs the motion of the second elongate shaft in a substantially longitudinal direction.
- the presence of the interstitial member between the outer surface of the second elongate shaft and the inner surface of the first elongate shaft substantially precludes lateral movement of the second elongate shaft relative to the first elongate shaft.
- FIG. 1 is a plan view of a catheter including a shaft assembly in accordance with the present invention
- FIG. 2 is a diagrammatic view including the catheter of FIG. 1 and a patient;
- FIG. 3 is a lateral cross section view of the shaft assembly of the catheter of FIG. 1 and FIG. 2 ;
- FIG. 4 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention.
- FIG. 5 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention.
- FIG. 6 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention.
- FIG. 7 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention.
- FIG. 8 is a plan view of an additional embodiment of a catheter in accordance with the present invention.
- FIG. 9 is a cross sectional view of a distal. portion of a catheter in accordance with the present invention.
- FIG. 10 is a plan view of a catheter including a shaft assembly in accordance with the present invention.
- FIG. 11 is a partial cross section view of a distal portion of the catheter of FIG. 10 ;
- FIG. 12 is a partial cross section view of a distal portion of the catheter of FIG. 10 .
- FIG. 1 is a plan view of a catheter 120 including a shaft assembly 122 in accordance with the present invention.
- Shaft assembly 122 comprises a first elongate shaft 124 having a distal end 134 , a proximal end 144 , and an inner surface 154 defining a lumen 132 .
- Shaft assembly 122 also includes a second elongate shaft 126 slidingly disposed within lumen 132 of first elongate shaft 124 .
- Catheter 120 also includes a distal end 130 , and a proximal end 140 .
- Second elongate shaft 126 has an outer surface 138 , distal end 136 , and a proximal end 146 . In many applications it is desirable to advance distal end 136 of second elongate shaft 126 by a known distance relative to distal. end 134 of first elongate shaft 124 .
- a slider 142 is fixed to second elongate shaft 126 proximate proximal end 146 thereof.
- a portion of slider 142 is disposed within a cavity 148 defined by a housing 150 .
- housing 150 is fixed to first elongate shaft 124 proximate proximal end 144 thereof.
- a plurality of indicia 152 are disposed on a face 154 of housing 150 proximate slider 142 .
- a physician utilizing catheter 120 in a surgical procedure may move distal end 136 of second elongate shaft 126 a known distance relative to distal end 134 of first elongate shaft 124 .
- a physician may urge slider 142 distally while visually observing the travel of slider 142 relative to indicia 152 of housing 150 .
- the movement of slider 142 is translated via second elongate shaft 126 to distal end 136 thereof.
- interstitial member 156 between outer surface 138 of second elongate shaft 126 and inner surface 154 of first elongate shaft 124 substantially precludes lateral movement of second elongate shaft 126 relative to first elongate shaft 124 .
- second elongate shaft 126 forms a point 158 proximate distal end 136 thereof.
- Second elongate shaft also defines an injection port 160 proximate point 158 .
- a hub 164 is disposed about second elongate shaft 126 proximate proximal end 146 thereof. Hub 164 defines a proximal port 166 .
- proximal port 166 is in fluid communication with injection port 160 via an injection lumen 162 defined by second elongate shaft 126 .
- Catheter 120 of FIG. 1 may be generally referred to as an injection catheter. It is to be appreciated that a catheter in accordance with the present invention may comprise various types of catheters without deviating from the spirit and scope of the present invention.
- second elongate shaft 126 of catheter 120 comprises hypodermic tubing.
- Second elongate shaft 126 may comprise various metallic and non-metallic materials without deviating from the spirit and scope of the present invention. Examples of metallic materials which may be suitable in some applications include stainless steel, and nickel-titanium alloy.
- non-metallic materials which may be suitable in some applications are included in the list below which is not exhaustive: polycarbonate, poly(L-lactide) (PLLA), poly(D,L-lactide) (PLA), polyglycolide (PGA), poly(L-lactide-co-D,L-lactide) (PLLA/PLA), poly(L-lactide-co-glycolide) (PLLA/PGA), poly(D, L-lactide-co-glycolide) (PLA/PGA), poly(glycolide-co-trimethylene carbonate) (PGA/PTMC), polyethylene oxide (PEO), polydioxanone (PDS), polycaprolactone (PCL), polyhydroxylbutyrate (PHBT), poly(phosphazene), polyD,L-lactide-cocaprolactone) (PLA/PCL), poly(glycolide-co-caprolactone) (PGA/PCL), polyanhydrides (PAN), poly(ortho esters,
- first elongate shaft 124 of catheter 120 comprises an elongate tubular member including a reinforcement member (e.g., braided or coiled wire).
- Second elongate shaft 126 may comprise various metallic and non-metallic materials without deviating from the spirit and scope of the present invention.
- metallic materials which may be suitable in some applications include stainless steel, and nickel-titanium alloy.
- non-metallic materials which may be suitable in some applications include: polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC), polyurethane, polytetrafluoroethylene (PTFE), polyether block amide (PEBA), polyamide, and polyimide.
- FIG. 2 is a diagrammatic view including catheter 120 of FIG. 1 and a patient 20 .
- Patient 20 has a heart 22 and a vascular system 24 including a blood vessel 26 defining a blood vessel lumen 28 .
- Am access sheath 30 is partially disposed within a leg 32 of patient 20 .
- a distal end of access sheath 30 is disposed within blood vessel lumen 28 of blood vessel 26 .
- Access sheath 30 may aid in the introduction of catheter 120 into blood vessel lumen 28 .
- catheter 120 As shown in FIG. 2 , a portion of catheter 120 is disposed within blood vessel lumen 28 of blood vessel 26 . Distal end 130 (not visible in FIG. 2 ) of catheter 120 is disposed within heart 22 of patient 20 . In a preferred embodiment, distal end 130 of catheter 120 is disposed proximate a wall of heart 22 .
- a fluid source 34 is coupled to hub 164 disposed about second elongate shaft 126 of catheter 120 .
- fluid source 34 includes a variable volume chamber 36 defined by a body 38 .
- variable volume chamber 36 is in fluid communication with injection lumen 162 of second elongate shaft 126 .
- a plunger 40 is slidingly disposed within variable volume chamber 36 . Urging the plunger distally has the effect of urging fluid into injection lumen 162 of second elongate shaft 126 .
- a number of energy sources may be utilized to urge plunger 40 distally. Energy sources which may be suitable in some applications include springs, compressed gas, a human being, and electricity.
- fluid source 34 Various additional embodiments of fluid source 34 are possible without deviating from the spirit and scope of the present invention.
- fluid sources which may be suitable in some applications include syringes, peristaltic pumps, and an I.V. bag with pressure applied to an outer surface thereof.
- a method of injecting a fluid into heart 22 of patient 20 may be described with reference to FIG. 2 .
- the distal end of access sheath 30 may be inserted into blood vessel lumen 28 of blood vessel 26 .
- Distal end 130 of catheter 120 may be inserted into the lumen of access sheath 30 .
- Distal end 130 of catheter 120 may be advanced through access sheath 30 and into blood vessel lumen 28 of blood vessel 26 .
- Catheter 120 may be urged forward through vascular system 24 of patient 20 until distal end 130 is proximate the target tissue (e.g., a wall of heart 22 ).
- target tissue e.g., a wall of heart 22
- distal end 136 of second elongate shaft 126 is disposed within lumen 132 of first elongate shaft 124 during the above steps.
- second elongate shaft 126 may be advanced so that point 158 penetrates the bodily tissue at the target site.
- injection port 160 of second elongate shaft 126 disposed within the target tissue, fluid may be urged into the target tissue. For example, force may be applied to plunger 40 urging fluid out of fluid source 34 and into injection lumen 162 of second elongate shaft 126 . he addition of fluid from fluid source 34 results in the injection of fluid into the target tissue.
- a physician may advance point 158 and injection port 160 into the target tissue by urging slider 142 distally.
- a physician may determine the depth of penetration by visually observing the travel of slider 142 relative to indicia 152 of housing 150 .
- the movement of slider 142 is translated via second elongate shaft 126 to point 158 formed by second elongate shaft 126 proximate the distal end 136 thereof.
- the presence of interstitial member 156 between outer surface 138 of second elongate shaft 126 and inner surface 154 of first elongate shaft 124 directs the motion of second elongate shaft 126 in a substantially longitudinal direction.
- the fluid injected into the target area may include various therapeutic or diagnostic agents adapted to treat the medical condition which the physician is treating.
- methods in accordance with the present invention may be used in the treatment of a number of medical conditions.
- PMR percutaneous myocardial revascularization
- a plurality of wounds may be created in hibernating tissue of the heart. These wounds may be created by injecting a fluid into the tissue of the heart. As a result of these wounds, there will be increased blood flow to the myocardium caused in part by the body's healing response to the wound.
- One healing response of the body is sometimes referred to as angiogenesis.
- PMR improves a patient's condition through denervation.
- Denervation is the elimination of nerves. The creation of wounds during this procedure results in the elimination of nerve endings which were previously sending pain signals to the brain as a result of hibernating tissue.
- Suitable wounds may be created by injecting a fluid such as water, saline, or ringers solution into the heart tissue. Wound formation and revascularization of myocardial tissue may enhanced by injecting a fluid including a therapeutic agent into the tissue of the heart. Examples of therapeutic agents which may be suitable include growth factors, drugs and caustic agents.
- the fluid injected into the heart tissue may also include a radiopaque material. Injecting a radiopaque material into the wound effectively marks the locations which have been treated. This will aid the physician in procedures which are being performed percutaneously using fluoroscopic equipment.
- catheter 120 may be utilized to inject fluid into heart 22 of patient 20 .
- catheter 120 may be utilized in the treatment of various medical conditions occurring in various locations in the body.
- catheter 120 may be used in the treatment of esophageal varices, a condition in which blood vessels of the esophagus are enlarged and may potentially burst.
- injection port 160 would be disposed proximate the enlarged varix and an appropriate agent would be injected into the varix.
- the agent may be a coagulant such as sodium morrhuate. When a coagulant is injected into a varix, it causes the occlusion thereof.
- FIG. 3 is a lateral cross section view of shaft assembly 122 of catheter 120 of 5 FIG. 1 and FIG. 2 .
- shaft assembly 122 includes second elongate shaft 126 which is disposed within lumen 132 defined by first elongate shaft 124 .
- a plurality of interstitial members 156 extend between first elongate shaft 124 and second elongate shaft 126 .
- each interstitial member comprises a longitudinal rib 168 .
- Each longitudinal rib 168 extends beyond an inner surface 154 of first elongate shaft 124 and contacts an outer surface 138 of second elongate shaft 126 .
- longitudinal ribs 168 are in contact with outer surface 138 of second elongate shaft 126 it may be appreciated that there is substantially no gap between longitudinal ribs 168 and second elongate shaft 126 .
- the gap between second elongate shaft 126 and each longitudinal rib 168 is, for example, between zero and 0.05 mm.
- Embodiments of the present invention are possible in which there is an interference fit between longitudinal ribs 168 and second elongate shaft 126 .
- second elongate shaft 126 defines an injection lumen 162 .
- FIG. 4 is a partial cross section view of an additional embodiment of a shaft assembly 222 in accordance with the present invention.
- Shaft assembly 222 includes a second elongate shaft 226 disposed within a lumen 232 defined by an inner surface 254 of a first elongate shaft 224 .
- First elongate shaft 224 also includes a plurality of interstitial members 256 extending beyond inner surface 254 of first elongate shaft 224 .
- each interstitial member comprises a radial rib 270 .
- each radial rib 270 contacts an outer surface 238 of second elongate shaft 226 .
- radial ribs 270 are in contact with outer surface 238 of second elongate shaft 226 it may be appreciated that there is substantially no gap between radial ribs 270 and second elongate shaft 226 .
- the gap between second elongate shaft 226 and each radial rib 270 is, for example, between zero and 0.05 mm.
- Embodiments of the present invention are possible in which there is an interference fit between radial ribs 270 and second elongate shaft 226 .
- FIG. 5 is a partial cross section view of an additional embodiment of a shaft assembly 322 in accordance with the present invention.
- Shaft assembly 322 includes a first elongate shaft 324 having a lumen 332 defined by an inner surface 354 thereof.
- a second elongate shaft 326 and an interstitial member 356 are disposed within lumen 332 of first elongate shaft 324 .
- interstitial member comprises a coil 372 comprising a wire 376 forming a plurality of turns 374 .
- each turn 374 of coil 372 is disposed between inner surface 354 of first elongate shaft 324 and outer surface 338 of second elongate shaft 326 .
- each turn 374 is in contact with inner surface 354 of first elongate shaft 324 and outer surface 338 of second elongate shaft 326 .
- FIG. 6 is a partial cross section view of an additional embodiment of a shaft assembly 422 in accordance with the present invention.
- Shaft assembly 422 includes a first elongate shaft 424 having a lumen 432 defined by an inner surface 454 thereof.
- a second elongate shaft 426 and an interstitial member 456 are disposed within lumen 432 of first elongate shaft 424 .
- interstitial member comprises a coil 472 comprising a wire 476 forming a plurality of turns 474 .
- coil 472 has a first pitch diameter A and a second pitch diameter B.
- coil 472 is preferably adapted to contact outer surface 438 of second elongate shaft 426 with a plurality of turns 474 .
- coil 472 is preferably adapted to contact inner surface 454 of first elongate shaft 424 with a plurality of turns.
- first pitch diameter A may be pre-selected such that a plurality of turns 474 of coil 472 will contact outer surface 438 of second elongate shaft 426 .
- second pitch diameter B may be pre-selected such that a plurality of turns 474 of coil 472 will contact inner surface 454 of first elongate shaft 424 .
- FIG. 7 is a partial cross section view of an additional embodiment of a shaft assembly 522 in accordance with the present invention.
- Shaft assembly 522 includes a first elongate shaft 524 having a lumen 532 defined by an inner surface 554 thereof.
- a second elongate shaft 526 is disposed within lumen 532 of first elongate shaft 524 .
- Second elongate shaft 526 includes an outer surface 538 and a plurality of interstitial members 556 .
- each interstitial member 556 comprises a projection 578 extending beyond outer surface 538 of second elongate shaft 526 .
- FIG. 8 is a plan view of an additional embodiment of a catheter 620 in accordance with the present invention.
- Catheter 620 has a distal end 630 , a proximal end 640 , and a shaft assembly 622 .
- Shaft assembly 622 comprises a first elongate shaft 624 having a distal end 634 , a proximal end 644 , and an inner surface 654 defining a lumen 632 .
- Shaft assembly 622 also includes a second elongate shaft 626 slidingly disposed within lumen 632 of first elongate shaft 624 .
- Second elongate shaft 626 has an outer surface 638 , a distal end 636 , and a proximal end 646 . In many applications it is desirable to advance distal end 636 of second elongate shaft 626 by a known distance relative to distal end 634 of first elongate shaft 624 .
- a plurality of indicia 652 are disposed on outer surface 638 of second elongate shaft 626 proximate a point 658 of second elongate shaft 626 .
- indicia 652 are comprised of a radiopaque material.
- radiopaque filler examples include barium sulfate, bismuth subcarbonate, bismuth trioxide, bismuth oxychloride, tungsten, and depleted uranium.
- a radiopaque reference 680 is disposed proximate distal end 634 of first elongate shaft 624 .
- a radiopaque reference 680 and indicia 652 may be viewed on a fluoroscopy screen. The image viewed on the fluoroscopy screen may be utilized to determine the depth which point 658 has penetrated into the target tissue.
- FIG. 9 is a cross sectional view of a distal portion 782 of a catheter 720 in accordance with the present invention.
- Catheter 720 comprises a first elongate shaft 724 having an inner surface 754 defining a lumen 732 .
- a ferrule 784 is disposed within lumen 732 proximate a distal end 734 of first elongate shaft 724 .
- ferrule 784 is fixed to first elongate shaft 724 .
- a needle 786 is slidingly disposed within a ferrule lumen 794 defined by ferrule 784 .
- a piston member 788 is disposed about a proximal portion 791 of needle 786 .
- Piston member 788 forms a sliding seal with inner surface 754 of first elongate shaft 724 .
- a spring 792 is disposed within lumen 732 of first elongate shaft 724 . In the embodiment of FIG. 9 , the distal end of spring 792 is seated against ferrule 784 and the proximal end of spring 792 is seated against piston member 788 .
- a fluid 790 is disposed within lumen 732 of first elongate shaft 724 and a needle lumen 796 defined by needle 786 .
- Catheter 720 of FIG. 9 may be utilized to inject fluid 790 into a target tissue.
- a fluid source may be utilized to urge additional fluid 790 into lumen 732 of first elongate shaft 724 and a needle lumen 796 defined by needle 786 .
- the additional fluid 790 is urged into lumen 732 with a velocity which is sufficient to create a pressure differential across piston member 788 .
- the pressure differential across piston member 788 is sufficient to compress spring 792 and urge an injection port 760 of needle 786 into the target tissue. In this manner a dose of fluid 790 may be injected into the target tissue.
- spring 792 will urge piston member 788 back to the position shown in FIG. 9 .
- the fluid source may include a variable volume chamber in fluid communication with lumen 732 of first elongate shaft 724 .
- the fluid source may further include a plunger slidingly disposed within the variable volume chamber. Urging the plunger distally preferably has the effect of urging fluid into lumen 732 of first elongate shaft 724 .
- a number of energy sources may be utilized to urge the plunger distally. Energy sources which may be suitable in some applications include springs, compressed gas, a human being, and electricity.
- FIG. 10 is a plan view of a catheter 920 in accordance with the present invention.
- Catheter 920 includes a distal. end 930 , a proximal end 940 , and a shaft assembly 922 .
- Shaft assembly 922 comprises a first elongate shaft 924 having a distal end 934 , a proximal end 944 , and an inner surface 954 defining a lumen 932 .
- Shaft assembly 922 also includes a second elongate shaft 926 slidingly disposed within lumen 932 of first elongate shaft 924 , which may function as the interstitial member described above.
- a third elongate shaft 970 is slidingly disposed within a lumen defined by second elongate shaft 926 .
- a proximal portion 945 of second elongate shaft 926 extends beyond proximal end 944 of first elongate shaft 924 .
- Proximal portion 945 of second elongate shaft 926 terminates with a proximal end 946 .
- a slider 942 is fixed to second elongate shaft 926 proximate proximal end 946 thereof.
- a portion of slider 942 is disposed within a cavity 948 (also referred to as a chamber) defined by a housing 950 (also referred to as a hub).
- housing 950 is fixed to first elongate shaft 924 proximate proximal end 944 thereof. Also in a preferred embodiment, a plurality of indicia 952 are disposed on a face 954 of housing 950 proximate slider 942 .
- FIG. 11 is a partial cross section view of a distal portion of catheter 920 of FIG. 10 .
- catheter 920 includes a first elongate shaft 924 , a second elongate shaft 926 , and a third elongate shaft 970 .
- third elongate shaft 970 forms a point 958 proximate a distal. end 976 thereof.
- Third elongate shaft 970 also defines an injection port 960 in fluid communication with an injection lumen.
- a flange 972 is disposed about third elongate shaft 970 . Flange 972 cooperates with a mechanical stop 974 in order to limit the travel of third elongate shaft 970 .
- mechanical stop 974 is fixed to second elongate shaft 926 proximate to distal end 936 thereof, forming an interstitial member between first elongated shaft 924 and the third elongate shaft 970 .
- the depth which third elongate shaft 970 will penetrate into a target tissue may be adjusted by moving distal end 936 of second elongate shaft 926 a known distance relative to distal end 934 of first elongate shaft 924 .
- a physician utilizing catheter 920 may urge slider 942 distally while visually observing the travel of slider 942 relative to indicia 952 of housing 950 .
- first elongate shaft 924 and second elongate shaft 926 there is, preferably, interference fit between first elongate shaft 924 and second elongate shaft 926 to eliminate any slop, whether second elongated shaft 926 is tubular or comprises radial ribs, as illustrated in FIG. 11 .
- FIG. 12 is a partial cross section view of a distal portion of catheter 920 of FIG. 10 and FIG. 11 .
- distal end 936 of second elongate shaft 926 has been moved to a new position relative to distal. end 934 of first elongate shaft 924 .
- the position of second elongate shaft 926 illustrated in FIG. 12 may be referred to as a second position, and the position of second elongate shaft illustrated in FIG. 11 may be referred to as a first position.
- second elongate shaft 926 may be urged proximally and distally to a plurality of positions.
- An injection may be performed by urging point. 958 of third elongate shaft 970 distally into a target tissue. The advancement of third elongate shaft 970 into the target tissue may be stopped when flange 972 seats against mechanical stop 974 .
Abstract
A catheter assembly is disclosed. This assembly may include a first elongate member having an internal lumen and a distal portion, a second elongate member, slidable within the first elongate member, and a spacer positioned between the second elongate member and the first elongate member. In this example, the spacer may be positioned at bendable portions of the first elongate member and the second elongate member such that the spacer maintains a substantially uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
Description
- This application is a Continuation of application Ser. No. 09/635,083, filed on Aug. 8, 2000, now U.S. Pat. No. ______. That application is incorporated, in its entirety, by reference.
- The present invention relates generally to intravascular catheters for performing medical procedures. More particularly, the present invention relates to shaft assemblies for use in intravascular catheters. Still, more particularly, the present invention relates to catheter shaft assemblies for use in injection catheters.
- Intravascular catheters are currently utilized in a wide variety of minimally invasive or percutaneous medical procedures. Generally, an intravascular catheter enables a physician to remotely perform a medical procedure by inserting the catheter into the vascular system of the patient at an easily accessible location and navigating the tip of the catheter to a desirable target site. By this method, virtually any target site in the patient's vascular system may be remotely accessed.
- Typically, a percutaneous procedure begins with the step of inserting a distal portion of the catheter into the patient's vasculature at a convenient location. Once the distal portion of the catheter has entered the patient's vascular system the physician may urge the distal tip forward by applying longitudinal forces to the proximal portion of the catheter. Frequently the path taken by a catheter through the vascular system is tortuous, requiring the catheter to change direction frequently. While advancing the catheter through the tortuous path of the patient's vasculature, the physician must steer the distal end of the catheter. During a percutaneous procedure, the physician typically is not able to manipulate the distal portion of the catheter directly. For this reason, physicians typically must steer the distal end of the catheter by applying torsional forces to the proximal portion of the catheter.
- Injection catheters are a type of catheter which may be used to inject therapeutic or diagnostic agents into various target tissues within the human body. An advantage of injection catheters is that the target tissue may be accessed utilizing minimally invasive surgical techniques. As with other types of catheters, the physician typically is not able to manipulate the distal portion of an injection catheter directly.
- In many applications the target tissue is within a wall of an organ such as the stomach or the heart. When the target tissue is within the wall of an organ it is often desirable to inject the therapeutic or diagnostic agent into the tissue proximate the center of the organ wall. If the needle of the injection catheter inadvertently passes through the wall, the therapeutic or diagnostic agents dispensed from the distal end of the needle will not be effectively delivered to the target tissue.
- One example of a medical procedure involving the delivery of a therapeutic and/or diagnostic agent to a targeted portion of a patient's body is the treatment of esophageal varices. This is a condition in which blood vessels of the esophagus are enlarged and may potentially burst. For such a procedure, a therapeutic agent is injected into the varix. When treating an esophageal varix, the agent may be a coagulant such as sodium morrhuate. When a coagulant is injected into a varix, it causes it to occlude. An injection catheter may be used to deliver the therapeutic agent in order to minimize the invasive nature of the procedure.
- In a similar procedure, an injection catheter may be utilized in the treatment of ulcers in the stomach lining. With such treatment, an injection catheter may be used to deliver drugs such as sclerosing or vasoconstrictive agents. These drugs typically clot or occlude the bleeding tissue to stop bleeding or to reduce the possibility of a blood vessel bursting.
- Injection catheters may also be used to inject therapeutic or diagnostic agents into the heart. Examples of agents delivered to the heart include genes, proteins, or drugs. In the case of injecting a therapeutic agent into the heart, 27 or 28 gauge needles are generally used to inject solutions carrying genes, proteins, or drugs directly into the myocardium. A typical volume of an agent delivered to an injection site is about 100 microliters.
- Therapeutic and diagnostic agents may be delivered to a portion of the heart as part of a percutaneous myocardial revascularization (PMR) procedure. PMR is a procedure which is aimed at assuring that the heart is properly oxygenated. Assuring that the heart muscle is adequately supplied with oxygen is critical to sustaining the life of a patient. To receive an adequate supply of oxygen, the heart muscle must be well perfused with blood. In a healthy heart, blood perfusion is accomplished with a system of blood vessels and capillaries. However, it is common for the blood vessels to become occluded (blocked) or stenoic (narrowed). A stenosis may be formed by an atheroma, which is typically a harder, calcified substance which forms on the walls of a blood vessel.
- Historically, individual stenotic lesions have been treated with a number of medical procedures including coronary bypass surgery, angioplasty, and atherectomy. Coronary bypass surgery typically involves utilizing vascular tissue from another part of the patient's body to construct a shunt around the obstructed vessel. Angioplasty techniques such as percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) are relatively non-invasive methods of treating a stenotic lesion. These angioplasty techniques typically involve the use of a guidewire and a balloon catheter. In these procedures, a balloon catheter is advanced over a guidewire such that the balloon is positioned proximate a restriction in a diseased vessel. The balloon is then inflated and the restriction in the vessel is opened. A third technique which may be used to treat a stenotic lesion is atherectomy. During an atherectomy procedure, the stenotic lesion is mechanically cut or abraded away from the blood vessel wall.
- Coronary by-pass, angioplasty, and atherectomy procedures have all been found effective in treating individual stenotic lesions in relatively large blood vessels. However, the heart muscle is perfused with blood through a network of small vessels and capillaries. In some cases, a large number of stenotic lesions may occur in a large number of locations throughout this network of small blood vessels and capillaries. The tortuous path and small diameter of these blood vessels limit access to the stenotic lesions. The sheer number and small size of these stenotic lesions make techniques such as cardiovascular by-pass surgery, angioplasty, and atherectomy impractical.
- When techniques which treat individual lesions are not practical, percutaneous myocardial revascularization (PMR) may be used to improve the oxygenation of the myocardial tissue. A PMR procedure generally involves the creation of holes, craters or channels directly into the myocardium of the heart. In a typical PMR procedure, these holes are created using radio frequency energy delivered by a catheter having one or more electrodes near its distal end. After the wound has been created, therapeutic agents are sometimes ejected into the heart chamber from the distal end of a catheter.
- Positive clinical results have been demonstrated in human patients receiving PMR treatments. These results are believed to be caused in part by blood flowing within a heart chamber through channels in myocardial tissue formed by PMR. Increased blood flow to the myocardium is also believed to be caused in part by the healing response to wound formation. Specifically, the formation of new blood vessels is believed to occur in response to the newly created wound. This response is sometimes referred to as angiogenesis. After the wound has been created, therapeutic agents which are intended to promote angiogenesis are sometimes ejected into the heart chamber. A limitation of this procedure is that the therapeutic agent may be quickly carried away by the flow of blood through the heart.
- In addition to promoting increased blood flow, it is also believed that PNM improves a patient's condition through denervation. Denervation is the elimination of nerves. The creation of wounds during a PMR procedure results in the elimination of nerve endings which were previously sending pain signals to the brain as a result of hibernating tissue.
- The present invention relates generally to intravascular catheters for performing medical procedures. More particularly, the present invention relates to shaft assemblies for use in intravascular catheters. Still, more particularly, the present invention relates to catheter shaft assemblies for use in injection catheters.
- This assembly may include a first elongate member having an internal lumen and a distal portion, a second elongate member, slidable within the first elongate member, and a spacer positioned between the second elongate member and the first elongate member. In this example, the spacer may be positioned at bendable portions of the first elongate member and the second elongate member such that the spacer maintains a substantially uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
- A shaft assembly in accordance with an exemplary embodiment of the present invention may also comprise a first elongate shaft having an inner surface defining a lumen, a second elongate shaft slidingly disposed within the lumen of the first elongate shaft, and an interstitial member disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate shaft.
- In one embodiment of a shaft assembly in accordance with the present invention a plurality of longitudinal ribs extend beyond an inner surface of the first elongate shaft. These longitudinal ribs preferably contact the outer surface of the second elongate shaft.
- In an additional embodiment of a shaft assembly in accordance with the present invention a radial rib extends beyond the inner surface of the first elongate shaft. The radial rib preferably contacts the outer surface of the second elongate shaft. When the radial rib is in contact with outer surface of second elongate shaft there is preferably no substantial gap between the radial rib and the outer surface of the second elongate shaft.
- An additional embodiment of a shaft assembly in accordance with the present invention includes a coil comprising a wire forming a plurality of turns. Each turn of the coil is disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate shaft.
- In an additional embodiment of a shaft assembly in accordance with the present invention the second elongate shaft has a plurality of projections extending beyond the outer surface of the second elongate shaft. When the second elongate shaft is disposed within the lumen defined by the first elongate shaft, these projections preferably contact the inner surface of the first elongate shaft.
- An injection catheter in accordance with an exemplary embodiment of the present invention includes a first elongate shaft having an inner surface defining a lumen. A second elongate shaft having an outer surface is slidingly disposed within the lumen of the first elongate shaft. In this exemplary embodiment, the second elongate shaft includes a point and an injection orifice proximate it's distal end. Also in this exemplary embodiment, an interstitial member is disposed between the inner surface of the first elongate shaft and the outer surface of the second elongate.
- In many applications it is desirable to advance the distal end of the second elongate shaft by a known distance relative to the distal end of the first elongate shaft. For example, when a physician wishes to inject a fluid into the wall of an organ. In one embodiment of a catheter in accordance with the present invention, a slider is fixed to the second elongate shaft proximate the proximal end thereof. Also in this embodiment, a portion of the slider is disposed within a cavity defined by a housing which is preferably fixed to the first elongate shaft proximate the proximal end thereof. Also in a preferred embodiment, a plurality of indicia are disposed on a face of the housing proximate the slider.
- A physician utilizing the catheter in a surgical procedure may move the distal end of the second elongate shaft a known distance relative to the distal end of the first elongate shaft. For example, a physician may urge the slider distally while visually observing the travel of the slider relative to the indicia of the housing. The movement of the slider is translated via the second elongate shaft to the distal end thereof.
- In a preferred embodiment there is substantially a one-to-one relationship between the movement of the slider relative to the indicia of the housing and the movement of the distal. end of the second elongate shaft relative to the distal end of the first elongate shaft. In a particularly preferred embodiment, the presence of an interstitial member between the outer surface of the second elongate shaft and the inner surface of the first elongate shaft directs the motion of the second elongate shaft in a substantially longitudinal direction. Also in a particularly preferred embodiment, the presence of the interstitial member between the outer surface of the second elongate shaft and the inner surface of the first elongate shaft substantially precludes lateral movement of the second elongate shaft relative to the first elongate shaft. Thus, it is assured that there will be substantially a one-to-one relationship between the movement of the slider relative to the indicia of the housing and the movement of the distal. end of the second elongate shaft relative to the distal end of the first elongate shaft.
-
FIG. 1 is a plan view of a catheter including a shaft assembly in accordance with the present invention; -
FIG. 2 is a diagrammatic view including the catheter ofFIG. 1 and a patient; -
FIG. 3 is a lateral cross section view of the shaft assembly of the catheter ofFIG. 1 andFIG. 2 ; -
FIG. 4 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention; -
FIG. 5 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention; -
FIG. 6 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention; -
FIG. 7 is a partial cross section view of an additional embodiment of a shaft assembly in accordance with the present invention; -
FIG. 8 is a plan view of an additional embodiment of a catheter in accordance with the present invention; -
FIG. 9 is a cross sectional view of a distal. portion of a catheter in accordance with the present invention; -
FIG. 10 is a plan view of a catheter including a shaft assembly in accordance with the present invention; -
FIG. 11 is a partial cross section view of a distal portion of the catheter ofFIG. 10 ; and -
FIG. 12 is a partial cross section view of a distal portion of the catheter ofFIG. 10 . - The following detailed description should be read with reference to the drawings, in which like elements in different drawings are numbered in like fashion. The drawings which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. In some cases, the drawings may be highly diagrammatic in nature. Examples of constructions, materials, dimensions, and manufacturing processes are provided for various elements. Those skilled in the art will recognize that many of the examples provided have suitable alternatives which may be utilized.
-
FIG. 1 is a plan view of acatheter 120 including ashaft assembly 122 in accordance with the present invention.Shaft assembly 122 comprises a firstelongate shaft 124 having adistal end 134, aproximal end 144, and aninner surface 154 defining alumen 132.Shaft assembly 122 also includes a secondelongate shaft 126 slidingly disposed withinlumen 132 of firstelongate shaft 124.Catheter 120 also includes adistal end 130, and aproximal end 140. - Second
elongate shaft 126 has anouter surface 138,distal end 136, and aproximal end 146. In many applications it is desirable to advancedistal end 136 of secondelongate shaft 126 by a known distance relative to distal. end 134 of firstelongate shaft 124. In the embodiment ofFIG. 1 , aslider 142 is fixed to secondelongate shaft 126 proximateproximal end 146 thereof. In the embodiment ofFIG. 1 , a portion ofslider 142 is disposed within acavity 148 defined by ahousing 150. In a presently preferred embodiment,housing 150 is fixed to firstelongate shaft 124 proximateproximal end 144 thereof. Also in a preferred embodiment, a plurality ofindicia 152 are disposed on aface 154 ofhousing 150proximate slider 142. - A
physician utilizing catheter 120 in a surgical procedure may movedistal end 136 of second elongate shaft 126 a known distance relative todistal end 134 of firstelongate shaft 124. For example, a physician may urgeslider 142 distally while visually observing the travel ofslider 142 relative toindicia 152 ofhousing 150. The movement ofslider 142 is translated via secondelongate shaft 126 todistal end 136 thereof. - In a preferred embodiment there is substantially a one-to-one relationship between the movement of
slider 142 relative toindicia 152 ofhousing 150 and the movement ofdistal end 136 of secondelongate shaft 126 relative todistal end 134 of firstelongate shaft 124. In a particularly preferred embodiment, the presence of aninterstitial member 156 betweenouter surface 138 of secondelongate shaft 126 andinner surface 154 of firstelongate shaft 124 directs the motion of secondelongate shaft 126 in a substantially longitudinal direction. Also in a particularly preferred embodiment, the presence ofinterstitial member 156 betweenouter surface 138 of secondelongate shaft 126 andinner surface 154 of firstelongate shaft 124 substantially precludes lateral movement of secondelongate shaft 126 relative to firstelongate shaft 124. Thus, it is assured that there will be substantially a one-to-one relationship between the movement ofslider 142 relative toindicia 152 ofhousing 150 and the movement ofdistal end 136 of secondelongate shaft 126 relative todistal end 134 of firstelongate shaft 124. - In the embodiment of
FIG. 1 , secondelongate shaft 126 forms apoint 158 proximatedistal end 136 thereof. Second elongate shaft also defines aninjection port 160proximate point 158. Ahub 164 is disposed about secondelongate shaft 126 proximateproximal end 146 thereof.Hub 164 defines aproximal port 166. In a preferred embodiment,proximal port 166 is in fluid communication withinjection port 160 via aninjection lumen 162 defined by secondelongate shaft 126. -
Catheter 120 ofFIG. 1 may be generally referred to as an injection catheter. It is to be appreciated that a catheter in accordance with the present invention may comprise various types of catheters without deviating from the spirit and scope of the present invention. - In a preferred embodiment, second
elongate shaft 126 ofcatheter 120 comprises hypodermic tubing. Secondelongate shaft 126 may comprise various metallic and non-metallic materials without deviating from the spirit and scope of the present invention. Examples of metallic materials which may be suitable in some applications include stainless steel, and nickel-titanium alloy. Examples of non-metallic materials which may be suitable in some applications are included in the list below which is not exhaustive: polycarbonate, poly(L-lactide) (PLLA), poly(D,L-lactide) (PLA), polyglycolide (PGA), poly(L-lactide-co-D,L-lactide) (PLLA/PLA), poly(L-lactide-co-glycolide) (PLLA/PGA), poly(D, L-lactide-co-glycolide) (PLA/PGA), poly(glycolide-co-trimethylene carbonate) (PGA/PTMC), polyethylene oxide (PEO), polydioxanone (PDS), polycaprolactone (PCL), polyhydroxylbutyrate (PHBT), poly(phosphazene), polyD,L-lactide-cocaprolactone) (PLA/PCL), poly(glycolide-co-caprolactone) (PGA/PCL), polyanhydrides (PAN), poly(ortho esters), poly(phoshate ester), poly(amino acid), poly(hydroxy butyrate), polyacrylate, polyacrylamid, poly(hydroxyethyl methacrylate), polyurethane, polysiloxane and their copolymers. - In a preferred embodiment, first
elongate shaft 124 ofcatheter 120 comprises an elongate tubular member including a reinforcement member (e.g., braided or coiled wire). Secondelongate shaft 126 may comprise various metallic and non-metallic materials without deviating from the spirit and scope of the present invention. Examples of metallic materials which may be suitable in some applications include stainless steel, and nickel-titanium alloy. Examples of non-metallic materials which may be suitable in some applications include: polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC), polyurethane, polytetrafluoroethylene (PTFE), polyether block amide (PEBA), polyamide, and polyimide. -
FIG. 2 is a diagrammaticview including catheter 120 ofFIG. 1 and apatient 20.Patient 20 has aheart 22 and avascular system 24 including ablood vessel 26 defining ablood vessel lumen 28. Amaccess sheath 30 is partially disposed within a leg 32 ofpatient 20. A distal end ofaccess sheath 30 is disposed withinblood vessel lumen 28 ofblood vessel 26.Access sheath 30 may aid in the introduction ofcatheter 120 intoblood vessel lumen 28. - As shown in
FIG. 2 , a portion ofcatheter 120 is disposed withinblood vessel lumen 28 ofblood vessel 26. Distal end 130 (not visible inFIG. 2 ) ofcatheter 120 is disposed withinheart 22 ofpatient 20. In a preferred embodiment,distal end 130 ofcatheter 120 is disposed proximate a wall ofheart 22. - In the embodiment of
FIG. 2 , afluid source 34 is coupled tohub 164 disposed about secondelongate shaft 126 ofcatheter 120. In the embodiment ofFIG. 2 ,fluid source 34 includes avariable volume chamber 36 defined by abody 38. In a preferred embodiment,variable volume chamber 36 is in fluid communication withinjection lumen 162 of secondelongate shaft 126. Aplunger 40 is slidingly disposed withinvariable volume chamber 36. Urging the plunger distally has the effect of urging fluid intoinjection lumen 162 of secondelongate shaft 126. A number of energy sources may be utilized to urgeplunger 40 distally. Energy sources which may be suitable in some applications include springs, compressed gas, a human being, and electricity. Various additional embodiments offluid source 34 are possible without deviating from the spirit and scope of the present invention. Examples of fluid sources which may be suitable in some applications include syringes, peristaltic pumps, and an I.V. bag with pressure applied to an outer surface thereof. - A method of injecting a fluid into
heart 22 ofpatient 20 may be described with reference toFIG. 2 . The distal end ofaccess sheath 30 may be inserted intoblood vessel lumen 28 ofblood vessel 26.Distal end 130 ofcatheter 120 may be inserted into the lumen ofaccess sheath 30.Distal end 130 ofcatheter 120 may be advanced throughaccess sheath 30 and intoblood vessel lumen 28 ofblood vessel 26.Catheter 120 may be urged forward throughvascular system 24 ofpatient 20 untildistal end 130 is proximate the target tissue (e.g., a wall of heart 22). I nFIG. 2 it may be appreciated thatshaft assembly 122 ofcatheter 120 is bent in a plurality of locations to conform with a tortuous path defined byvascular system 24. - In a preferred method,
distal end 136 of secondelongate shaft 126 is disposed withinlumen 132 of firstelongate shaft 124 during the above steps. Oncedistal end 130 ofcatheter 120 is positioned proximate the target tissue, secondelongate shaft 126 may be advanced so thatpoint 158 penetrates the bodily tissue at the target site. Withinjection port 160 of secondelongate shaft 126 disposed within the target tissue, fluid may be urged into the target tissue. For example, force may be applied toplunger 40 urging fluid out offluid source 34 and intoinjection lumen 162 of secondelongate shaft 126. he addition of fluid fromfluid source 34 results in the injection of fluid into the target tissue. - In many applications it is desirable to advance
point 158 andinjection port 160 into the target tissue by a known distance. A physician may advancepoint 158 andinjection port 160 into the target tissue by urgingslider 142 distally. A physician may determine the depth of penetration by visually observing the travel ofslider 142 relative toindicia 152 ofhousing 150. - The movement of
slider 142 is translated via secondelongate shaft 126 to point 158 formed by secondelongate shaft 126 proximate thedistal end 136 thereof. In a preferred embodiment there is substantially a one-to-one relationship between the movement ofslider 142 relative toindicia 152 ofhousing 150 and the movement ofdistal end 136 of secondelongate shaft 126 relative todistal end 134 of firstelongate shaft 124. In a particularly preferred embodiment, the presence ofinterstitial member 156 betweenouter surface 138 of secondelongate shaft 126 andinner surface 154 of firstelongate shaft 124 directs the motion of secondelongate shaft 126 in a substantially longitudinal direction. - The fluid injected into the target area may include various therapeutic or diagnostic agents adapted to treat the medical condition which the physician is treating. It is to be appreciated that methods in accordance with the present invention may be used in the treatment of a number of medical conditions. For example, methods and devices of performing percutaneous myocardial revascularization (PMR) in accordance with the present invention have been envisioned. For example, a plurality of wounds may be created in hibernating tissue of the heart. These wounds may be created by injecting a fluid into the tissue of the heart. As a result of these wounds, there will be increased blood flow to the myocardium caused in part by the body's healing response to the wound. One healing response of the body is sometimes referred to as angiogenesis. In addition to promoting increased blood flow, it is also believed that PMR improves a patient's condition through denervation. Denervation is the elimination of nerves. The creation of wounds during this procedure results in the elimination of nerve endings which were previously sending pain signals to the brain as a result of hibernating tissue.
- Suitable wounds may be created by injecting a fluid such as water, saline, or ringers solution into the heart tissue. Wound formation and revascularization of myocardial tissue may enhanced by injecting a fluid including a therapeutic agent into the tissue of the heart. Examples of therapeutic agents which may be suitable include growth factors, drugs and caustic agents. The fluid injected into the heart tissue may also include a radiopaque material. Injecting a radiopaque material into the wound effectively marks the locations which have been treated. This will aid the physician in procedures which are being performed percutaneously using fluoroscopic equipment.
- In the exemplary embodiment of
FIG. 2 ,catheter 120 may be utilized to inject fluid intoheart 22 ofpatient 20. It is to be appreciated thatcatheter 120 may be utilized in the treatment of various medical conditions occurring in various locations in the body. For example,catheter 120 may be used in the treatment of esophageal varices, a condition in which blood vessels of the esophagus are enlarged and may potentially burst. For such a procedure,injection port 160 would be disposed proximate the enlarged varix and an appropriate agent would be injected into the varix. When treating an esophageal varice, the agent may be a coagulant such as sodium morrhuate. When a coagulant is injected into a varix, it causes the occlusion thereof. -
FIG. 3 is a lateral cross section view ofshaft assembly 122 ofcatheter 120 of 5FIG. 1 andFIG. 2 . As described above,shaft assembly 122 includes secondelongate shaft 126 which is disposed withinlumen 132 defined by firstelongate shaft 124. InFIG. 3 it may be appreciated that a plurality ofinterstitial members 156 extend between firstelongate shaft 124 and secondelongate shaft 126. In the embodiment ofFIG. 3 , each interstitial member comprises alongitudinal rib 168. Eachlongitudinal rib 168 extends beyond aninner surface 154 of firstelongate shaft 124 and contacts anouter surface 138 of secondelongate shaft 126. Sincelongitudinal ribs 168 are in contact withouter surface 138 of secondelongate shaft 126 it may be appreciated that there is substantially no gap betweenlongitudinal ribs 168 and secondelongate shaft 126. In a presently preferred embodiment, the gap between secondelongate shaft 126 and eachlongitudinal rib 168 is, for example, between zero and 0.05 mm. Embodiments of the present invention are possible in which there is an interference fit betweenlongitudinal ribs 168 and secondelongate shaft 126. InFIG. 3 , it may also be appreciated that secondelongate shaft 126 defines aninjection lumen 162. -
FIG. 4 is a partial cross section view of an additional embodiment of ashaft assembly 222 in accordance with the present invention.Shaft assembly 222 includes a secondelongate shaft 226 disposed within alumen 232 defined by aninner surface 254 of a firstelongate shaft 224. Firstelongate shaft 224 also includes a plurality ofinterstitial members 256 extending beyondinner surface 254 of firstelongate shaft 224. In the embodiment ofFIG. 4 , each interstitial member comprises aradial rib 270. As shown inFIG. 4 , eachradial rib 270 contacts anouter surface 238 of secondelongate shaft 226. Sinceradial ribs 270 are in contact withouter surface 238 of secondelongate shaft 226 it may be appreciated that there is substantially no gap betweenradial ribs 270 and secondelongate shaft 226. In a presently preferred embodiment, the gap between secondelongate shaft 226 and eachradial rib 270 is, for example, between zero and 0.05 mm. Embodiments of the present invention are possible in which there is an interference fit betweenradial ribs 270 and secondelongate shaft 226. -
FIG. 5 is a partial cross section view of an additional embodiment of ashaft assembly 322 in accordance with the present invention.Shaft assembly 322 includes a firstelongate shaft 324 having alumen 332 defined by aninner surface 354 thereof. A secondelongate shaft 326 and aninterstitial member 356 are disposed withinlumen 332 of firstelongate shaft 324. In the embodiment ofFIG. 5 , interstitial member comprises acoil 372 comprising awire 376 forming a plurality ofturns 374. As shown inFIG. 5 , eachturn 374 ofcoil 372 is disposed betweeninner surface 354 of firstelongate shaft 324 andouter surface 338 of secondelongate shaft 326. I n the embodiment ofFIG. 5 , eachturn 374 is in contact withinner surface 354 of firstelongate shaft 324 andouter surface 338 of secondelongate shaft 326. -
FIG. 6 is a partial cross section view of an additional embodiment of ashaft assembly 422 in accordance with the present invention.Shaft assembly 422 includes a firstelongate shaft 424 having alumen 432 defined by aninner surface 454 thereof. A secondelongate shaft 426 and aninterstitial member 456 are disposed withinlumen 432 of firstelongate shaft 424. In the embodiment ofFIG. 6 , interstitial member comprises acoil 472 comprising awire 476 forming a plurality ofturns 474. - In the embodiment of
FIG. 6 ,coil 472 has a first pitch diameter A and a second pitch diameter B. In the embodiment ofFIG. 6 ,coil 472 is preferably adapted to contactouter surface 438 of secondelongate shaft 426 with a plurality ofturns 474. Also in the embodiment ofFIG. 6 ,coil 472 is preferably adapted to contactinner surface 454 of firstelongate shaft 424 with a plurality of turns. For example, first pitch diameter A may be pre-selected such that a plurality ofturns 474 ofcoil 472 will contactouter surface 438 of secondelongate shaft 426. By way of a second example, second pitch diameter B may be pre-selected such that a plurality ofturns 474 ofcoil 472 will contactinner surface 454 of firstelongate shaft 424. -
FIG. 7 is a partial cross section view of an additional embodiment of ashaft assembly 522 in accordance with the present invention.Shaft assembly 522 includes a firstelongate shaft 524 having alumen 532 defined by aninner surface 554 thereof. A secondelongate shaft 526 is disposed withinlumen 532 of firstelongate shaft 524. Secondelongate shaft 526 includes anouter surface 538 and a plurality ofinterstitial members 556. In the embodiment ofFIG. 7 , eachinterstitial member 556 comprises aprojection 578 extending beyondouter surface 538 of secondelongate shaft 526. -
FIG. 8 is a plan view of an additional embodiment of acatheter 620 in accordance with the present invention.Catheter 620 has a distal end 630, aproximal end 640, and ashaft assembly 622.Shaft assembly 622 comprises a firstelongate shaft 624 having adistal end 634, aproximal end 644, and an inner surface 654 defining a lumen 632.Shaft assembly 622 also includes a secondelongate shaft 626 slidingly disposed within lumen 632 of firstelongate shaft 624. - Second
elongate shaft 626 has anouter surface 638, adistal end 636, and aproximal end 646. In many applications it is desirable to advancedistal end 636 of secondelongate shaft 626 by a known distance relative todistal end 634 of firstelongate shaft 624. In the embodiment ofFIG. 8 , a plurality ofindicia 652 are disposed onouter surface 638 of secondelongate shaft 626 proximate apoint 658 of secondelongate shaft 626. In a preferred embodiment,indicia 652 are comprised of a radiopaque material. Examples of materials which may be suitable in some applications include gold, platinum, tungsten, iron, silver, and thermoplastic material loaded with a radiopaque filler. Examples of radiopaque filler which may be suitable in some applications include barium sulfate, bismuth subcarbonate, bismuth trioxide, bismuth oxychloride, tungsten, and depleted uranium. - A
radiopaque reference 680 is disposed proximatedistal end 634 of firstelongate shaft 624. During surgery aradiopaque reference 680 andindicia 652 may be viewed on a fluoroscopy screen. The image viewed on the fluoroscopy screen may be utilized to determine the depth which point 658 has penetrated into the target tissue. -
FIG. 9 is a cross sectional view of adistal portion 782 of acatheter 720 in accordance with the present invention.Catheter 720 comprises a firstelongate shaft 724 having aninner surface 754 defining alumen 732. Aferrule 784 is disposed withinlumen 732 proximate adistal end 734 of firstelongate shaft 724. In a preferred embodiment,ferrule 784 is fixed to firstelongate shaft 724. Aneedle 786 is slidingly disposed within aferrule lumen 794 defined byferrule 784. A piston member 788 is disposed about aproximal portion 791 ofneedle 786. Piston member 788 forms a sliding seal withinner surface 754 of firstelongate shaft 724. Aspring 792 is disposed withinlumen 732 of firstelongate shaft 724. In the embodiment ofFIG. 9 , the distal end ofspring 792 is seated againstferrule 784 and the proximal end ofspring 792 is seated against piston member 788. - In
FIG. 9 , a fluid 790 is disposed withinlumen 732 of firstelongate shaft 724 and aneedle lumen 796 defined byneedle 786.Catheter 720 ofFIG. 9 may be utilized to inject fluid 790 into a target tissue. A fluid source may be utilized to urgeadditional fluid 790 intolumen 732 of firstelongate shaft 724 and aneedle lumen 796 defined byneedle 786. In a preferred method, theadditional fluid 790 is urged intolumen 732 with a velocity which is sufficient to create a pressure differential across piston member 788. In this preferred method, the pressure differential across piston member 788 is sufficient to compressspring 792 and urge aninjection port 760 ofneedle 786 into the target tissue. In this manner a dose offluid 790 may be injected into the target tissue. When the flow offluid 790 stops,spring 792 will urge piston member 788 back to the position shown inFIG. 9 . - Those of skill in the art will appreciate that many embodiments of the fluid source are possible without deviating from the spirit and scope of the present invention. For example, the fluid source may include a variable volume chamber in fluid communication with
lumen 732 of firstelongate shaft 724. In this exemplary embodiment, the fluid source may further include a plunger slidingly disposed within the variable volume chamber. Urging the plunger distally preferably has the effect of urging fluid intolumen 732 of firstelongate shaft 724. A number of energy sources may be utilized to urge the plunger distally. Energy sources which may be suitable in some applications include springs, compressed gas, a human being, and electricity. -
FIG. 10 is a plan view of acatheter 920 in accordance with the present invention.Catheter 920 includes a distal. end 930, aproximal end 940, and ashaft assembly 922.Shaft assembly 922 comprises a firstelongate shaft 924 having adistal end 934, aproximal end 944, and an inner surface 954 defining a lumen 932.Shaft assembly 922 also includes a secondelongate shaft 926 slidingly disposed within lumen 932 of firstelongate shaft 924, which may function as the interstitial member described above. A thirdelongate shaft 970 is slidingly disposed within a lumen defined by secondelongate shaft 926. In the embodiment ofFIG. 10 , aproximal portion 945 of secondelongate shaft 926 extends beyondproximal end 944 of firstelongate shaft 924.Proximal portion 945 of secondelongate shaft 926 terminates with aproximal end 946. Also in the embodiment ofFIG. 10 , aslider 942 is fixed to secondelongate shaft 926 proximateproximal end 946 thereof. A portion ofslider 942 is disposed within a cavity 948 (also referred to as a chamber) defined by a housing 950 (also referred to as a hub). In a presently preferred embodiment,housing 950 is fixed to firstelongate shaft 924 proximateproximal end 944 thereof. Also in a preferred embodiment, a plurality ofindicia 952 are disposed on a face 954 ofhousing 950proximate slider 942. -
FIG. 11 is a partial cross section view of a distal portion ofcatheter 920 ofFIG. 10 . As described previously,catheter 920 includes a firstelongate shaft 924, a secondelongate shaft 926, and a thirdelongate shaft 970. In a preferred embodiment, thirdelongate shaft 970 forms apoint 958 proximate a distal. end 976 thereof. Thirdelongate shaft 970 also defines aninjection port 960 in fluid communication with an injection lumen. Aflange 972 is disposed about thirdelongate shaft 970.Flange 972 cooperates with amechanical stop 974 in order to limit the travel of thirdelongate shaft 970. In a preferred embodiment,mechanical stop 974 is fixed to secondelongate shaft 926 proximate todistal end 936 thereof, forming an interstitial member between firstelongated shaft 924 and the thirdelongate shaft 970. The depth which thirdelongate shaft 970 will penetrate into a target tissue (e.g., a heart wall) may be adjusted by movingdistal end 936 of second elongate shaft 926 a known distance relative todistal end 934 of firstelongate shaft 924. For example, aphysician utilizing catheter 920 may urgeslider 942 distally while visually observing the travel ofslider 942 relative toindicia 952 ofhousing 950. In a preferred embodiment there is substantially a one-to-one relationship between the movement ofslider 942 relative toindicia 952 ofhousing 950 and the movement ofdistal end 936 of secondelongate shaft 926 relative todistal end 934 of firstelongate shaft 924. In the embodiment ofFIG. 11 , there is, preferably, interference fit between firstelongate shaft 924 and secondelongate shaft 926 to eliminate any slop, whether secondelongated shaft 926 is tubular or comprises radial ribs, as illustrated inFIG. 11 . -
FIG. 12 is a partial cross section view of a distal portion ofcatheter 920 ofFIG. 10 andFIG. 11 . In the embodiment ofFIG. 12 ,distal end 936 of secondelongate shaft 926 has been moved to a new position relative to distal. end 934 of firstelongate shaft 924. The position of secondelongate shaft 926 illustrated inFIG. 12 may be referred to as a second position, and the position of second elongate shaft illustrated inFIG. 11 may be referred to as a first position. It is to be appreciated that secondelongate shaft 926 may be urged proximally and distally to a plurality of positions. An injection may be performed by urging point. 958 of thirdelongate shaft 970 distally into a target tissue. The advancement of thirdelongate shaft 970 into the target tissue may be stopped when flange 972 seats againstmechanical stop 974. - Having thus described the preferred embodiments of the present invention, those of skill in the art will readily appreciate that yet other embodiments may be made and used within the scope of the claims hereto attached. Numerous advantages of the invention covered by this document have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Claims (17)
1. A catheter assembly comprising:
a first elongate member having an internal lumen and a distal portion, the first elongate member sized for insertion into a body of a patient;
a second elongate member,
the second elongate member also having an internal lumen,
the second elongate member slidable within the first elongate member,
the second elongate member having a delivery end extendible outside of the
distal portion of the first elongate member,
a spacer positioned between the second elongate member and the first elongate member,
the spacer positioned at bendable portions of the first elongate member and the second elongate member,
the spacer maintaining a substantially uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
2. The catheter system of claim 1 wherein the distance of insertion of a proximal end of the second elongate member is substantially equal to the distance of extension of the delivery end of the second elongate member away from the distal portion of the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
3. The catheter system of claim 1 wherein the delivery end of the second elongate member is a piercing tip.
4. The catheter system of claim 1 wherein the first elongate member and the second elongate member are tubes having circular cross-sections.
5. The catheter system of claim 1 further comprising:
a scale, the scale coupled to the first elongate member, the containing indices that reflect the length of extension of the delivery end of the second elongate member from the distal portion of the first elongate member.
6. The catheter system of claim 1 wherein the delivery end of the second elongate member contains a marker.
7. The catheter system of claim 6 wherein the marker is a radiopaque marker.
8. The catheter system of claim 1 wherein the spacer extends along at least half of the length of second elongate member.
9. The catheter system of claim 1 wherein the spacer is mounted to the first elongate member.
10. The catheter system of claim 1 wherein the spacer is mounted to the second elongate member.
11. The catheter system of claim 1 wherein the spacer extends along the entire length of the first elongate member.
12. The catheter syst6em of claim 1 wherein the second elongate member is coupled to a source of therapeutic.
13. The catheter of claim 1 wherein the spacer defines uniform gaps along bendable portions of the first elongate member and bendable portions of the second elongate member, the gaps being uniform when the first elongate member is straight and the second elongate member is straight.
14. The catheter of claim 1 wherein the spacer comprises a plurality of individual contact points between the first elongate member and the second elongate member.
15. The catheter system of claim 1 wherein the first elongate member is sized to fit within arterial lumens of a human.
16. The catheter system of claim 1 wherein the spacer maintains a uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
17. The catheter system of claim 1 further comprising:
a second spacer positioned between the second elongate member and the first elongate member,
the second spacer positioned at bendable portions of the first elongate member and the second elongate member,
the second spacer maintaining a substantially uniform spacing between the second elongate member and the first elongate member when the first elongate member and the second elongate member are in a curved orientation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/979,233 US20050065474A1 (en) | 2000-08-08 | 2004-11-03 | Catheter assembly |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/635,083 US6893421B1 (en) | 2000-08-08 | 2000-08-08 | Catheter shaft assembly |
US10/979,233 US20050065474A1 (en) | 2000-08-08 | 2004-11-03 | Catheter assembly |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/635,083 Continuation US6893421B1 (en) | 2000-08-08 | 2000-08-08 | Catheter shaft assembly |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050065474A1 true US20050065474A1 (en) | 2005-03-24 |
Family
ID=24546375
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/635,083 Expired - Lifetime US6893421B1 (en) | 2000-08-08 | 2000-08-08 | Catheter shaft assembly |
US10/979,233 Abandoned US20050065474A1 (en) | 2000-08-08 | 2004-11-03 | Catheter assembly |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/635,083 Expired - Lifetime US6893421B1 (en) | 2000-08-08 | 2000-08-08 | Catheter shaft assembly |
Country Status (7)
Country | Link |
---|---|
US (2) | US6893421B1 (en) |
EP (1) | EP1311316B1 (en) |
JP (1) | JP2004505689A (en) |
AU (1) | AU2001279204A1 (en) |
CA (1) | CA2418149A1 (en) |
DE (1) | DE60109626T2 (en) |
WO (1) | WO2002011808A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050049609A1 (en) * | 2004-08-06 | 2005-03-03 | Scimed Life Systems, Inc. | Medical device delivery systems |
US20060015168A1 (en) * | 2004-07-13 | 2006-01-19 | Scimed Life Systems, Inc. | Catheter |
US20060047246A1 (en) * | 2004-08-24 | 2006-03-02 | 3Fi Products Llc | Catheter with retractable needle, and methods of use and manufacture |
US20060095110A1 (en) * | 2004-10-29 | 2006-05-04 | Scimed Life Systems, Inc. | Implantable medical endoprosthesis delivery systems and related components |
EP1731190A1 (en) * | 2005-05-31 | 2006-12-13 | BIOENGINEERING LABORATORIES S.p.A. | Assembly of a vascular drive device and a removable stiffening means |
US20080171985A1 (en) * | 2006-10-16 | 2008-07-17 | Y.K.K. Saglik Hizmetleri Limited Sirketi | Flexible and Rigid Catheter Resector Balloon |
US7803130B2 (en) | 2006-01-09 | 2010-09-28 | Vance Products Inc. | Deflectable tip access sheath |
US20110021911A1 (en) * | 2009-07-23 | 2011-01-27 | Silicon Valley Medical Instruments, Inc. | Endoventricular injection catheter system with integrated echocardiographic capabilities |
US20120157972A1 (en) * | 2006-02-03 | 2012-06-21 | Cannuflow, Inc. | Anti-Extravasation Sheath |
US20140031686A1 (en) * | 2009-05-29 | 2014-01-30 | Boston Scientific SclMed, Inc. | Systems and methods for making and using image-guided intravascular and endocardial therapy systems |
US8758231B2 (en) | 2009-05-14 | 2014-06-24 | Cook Medical Technologies Llc | Access sheath with active deflection |
WO2017079325A3 (en) * | 2015-11-03 | 2018-03-01 | Clph, Llc | Injection devices and systems and methods for using them |
WO2019066847A1 (en) * | 2017-09-28 | 2019-04-04 | C.R. Bard, Inc. | Catheter with movable indicator |
WO2019067790A3 (en) * | 2017-09-27 | 2019-05-23 | Clph, Llc | Injection devices and systems and methods for using them |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893421B1 (en) * | 2000-08-08 | 2005-05-17 | Scimed Life Systems, Inc. | Catheter shaft assembly |
US20020095203A1 (en) * | 2001-01-18 | 2002-07-18 | Intra Therapeutics, Inc. | Catheter system with spacer member |
US6796963B2 (en) * | 2001-07-10 | 2004-09-28 | Myocardial Therapeutics, Inc. | Flexible tissue injection catheters with controlled depth penetration |
US9949789B2 (en) | 2002-03-05 | 2018-04-24 | Avent, Inc. | Methods of treating the sacroiliac region of a patient's body |
US9364281B2 (en) * | 2002-03-05 | 2016-06-14 | Avent, Inc. | Methods for treating the thoracic region of a patient's body |
US20060259026A1 (en) * | 2005-05-05 | 2006-11-16 | Baylis Medical Company Inc. | Electrosurgical treatment method and device |
US20090024124A1 (en) * | 2005-07-14 | 2009-01-22 | Lefler Amy | Methods for treating the thoracic region of a patient's body |
US9216053B2 (en) * | 2002-03-05 | 2015-12-22 | Avent, Inc. | Elongate member providing a variation in radiopacity |
US20040176759A1 (en) * | 2003-03-07 | 2004-09-09 | Subashini Krishnamurthy | Radiopaque electrical needle |
US10206739B2 (en) * | 2002-03-05 | 2019-02-19 | Avent, Inc. | Electrosurgical device and methods |
US11291496B2 (en) | 2002-03-05 | 2022-04-05 | Avent, Inc. | Methods of treating the sacroiliac region of a patient's body |
US7819869B2 (en) * | 2004-11-15 | 2010-10-26 | Kimberly-Clark Inc. | Methods of treating the sacroilac region of a patient's body |
EP1386633A1 (en) * | 2002-08-02 | 2004-02-04 | Sergio Restelli | Safety catheter |
US7547304B2 (en) | 2002-12-19 | 2009-06-16 | Gore Enterprise Holdings, Inc. | Guidewire-centering catheter tip |
US20100185082A1 (en) * | 2003-03-07 | 2010-07-22 | Baylis Medical Company Inc. | Device and method for electrosurgery |
EP1680173B1 (en) * | 2003-10-31 | 2011-01-12 | Trudell Medical International | System for manipulating a catheter for delivering a substance to a body cavity |
US7678077B2 (en) | 2004-02-20 | 2010-03-16 | Boston Scientific Scimed, Inc. | Variable depth injection device and method |
US7699829B2 (en) | 2004-03-25 | 2010-04-20 | Boston Scientific Scimed, Inc. | Catheter with sensor tip and method of use of same |
US7678081B2 (en) * | 2004-07-12 | 2010-03-16 | Pacesetter, Inc. | Methods and devices for transseptal access |
US20060129126A1 (en) * | 2004-11-19 | 2006-06-15 | Kaplitt Michael G | Infusion device and method for infusing material into the brain of a patient |
US7517338B2 (en) | 2005-01-21 | 2009-04-14 | Boston Scientific Scimed, Inc. | Delivery of therapeutic through multiple delivery members |
JP2006271571A (en) * | 2005-03-29 | 2006-10-12 | Sumitomo Bakelite Co Ltd | Injection needle for endoscope |
US8114142B2 (en) * | 2005-03-30 | 2012-02-14 | Boston Scientific Scimed, Inc. | Catheter |
EP1957140A1 (en) * | 2005-12-05 | 2008-08-20 | B. Braun Melsungen Ag | Catheter tube |
US8038595B2 (en) | 2006-01-25 | 2011-10-18 | Beth Israel Deaconess Medical Center | Devices and methods for tissue transplant and regeneration |
US8287940B2 (en) | 2006-02-09 | 2012-10-16 | B. Braun Melsungen Ag | Coating method for a folded balloon |
US20070208407A1 (en) * | 2006-03-06 | 2007-09-06 | Michael Gerdts | Medical device delivery systems |
WO2007147058A2 (en) * | 2006-06-14 | 2007-12-21 | Cornova, Inc. | Method and apparatus for identifying and treating myocardial infarction |
EP1929945A3 (en) * | 2006-12-07 | 2009-01-14 | Arthrex, Inc. | Measuring device |
WO2008101003A1 (en) * | 2007-02-13 | 2008-08-21 | Cornova, Inc. | Biocompatible polymers, polymer tie-coats, methods of making and using the same, and products incorporating the polymers |
US20100069760A1 (en) * | 2008-09-17 | 2010-03-18 | Cornova, Inc. | Methods and apparatus for analyzing and locally treating a body lumen |
KR101109700B1 (en) * | 2009-09-07 | 2012-01-31 | 신경민 | Kadeteo prayer balloons |
US8663190B2 (en) | 2011-04-22 | 2014-03-04 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US9056185B2 (en) | 2011-08-24 | 2015-06-16 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US10881458B2 (en) | 2012-10-29 | 2021-01-05 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10945787B2 (en) | 2012-10-29 | 2021-03-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US8740849B1 (en) * | 2012-10-29 | 2014-06-03 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US9949652B2 (en) | 2013-10-25 | 2018-04-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US10517666B2 (en) | 2013-10-25 | 2019-12-31 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
EP3065805A1 (en) * | 2013-11-04 | 2016-09-14 | Nitiloop Ltd. | Microcatheter tubing arrangement |
US9839766B2 (en) * | 2014-10-20 | 2017-12-12 | Medtronic Cryocath Lp | Centering coiled guide |
GB201600202D0 (en) * | 2016-01-06 | 2016-02-17 | Gyrus Medical Ltd | Electrosurgical apparatus |
FR3066394B1 (en) * | 2017-05-22 | 2021-11-19 | Pierre Sarradon | ORIENTABLE CATHETER, DEVICE AND METHOD OF SURGICAL INTERVENTION |
CN109865186A (en) * | 2017-12-02 | 2019-06-11 | 山东朱氏药业集团有限公司 | A kind of brain suction tube |
US10849685B2 (en) | 2018-07-18 | 2020-12-01 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
Citations (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578061A (en) * | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
US4658817A (en) * | 1985-04-01 | 1987-04-21 | Children's Hospital Medical Center | Method and apparatus for transmyocardial revascularization using a laser |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
US4790311A (en) * | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
US4896671A (en) * | 1988-08-01 | 1990-01-30 | C. R. Bard, Inc. | Catheter with contoured ablation electrode |
US4940458A (en) * | 1989-02-02 | 1990-07-10 | Cohn Arnold K | Epidural needle placement system |
US4973321A (en) * | 1989-03-17 | 1990-11-27 | Michelson Gary K | Cannula for an arthroscope |
US5047026A (en) * | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
US5093877A (en) * | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5221269A (en) * | 1990-10-15 | 1993-06-22 | Cook Incorporated | Guide for localizing a nonpalpable breast lesion |
US5261889A (en) * | 1992-11-24 | 1993-11-16 | Boston Scientific Corporation | Injection therapy catheter |
US5267982A (en) * | 1988-04-29 | 1993-12-07 | C. R. Bard, Inc. | Variable shaped catheter system and method for catheterization |
US5287861A (en) * | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5353800A (en) * | 1992-12-11 | 1994-10-11 | Medtronic, Inc. | Implantable pressure sensor lead |
US5354279A (en) * | 1992-10-21 | 1994-10-11 | Bavaria Medizin Technologie Gmbh | Plural needle injection catheter |
US5358485A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5364393A (en) * | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5380316A (en) * | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5403311A (en) * | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5405376A (en) * | 1993-08-27 | 1995-04-11 | Medtronic, Inc. | Method and apparatus for ablation |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5464395A (en) * | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5480389A (en) * | 1994-08-09 | 1996-01-02 | Becton, Dickinson And Company | Method and apparatus for adjusting the length of a combined spinal-epidural needle |
US5507731A (en) * | 1994-05-17 | 1996-04-16 | Cordis Corporation | Rapid exchange segmented catheter |
US5522815A (en) * | 1993-03-29 | 1996-06-04 | Durgin, Jr.; Russell F. | Integrated catheter for diverse in situ tissue therapy |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
US5569462A (en) * | 1993-09-24 | 1996-10-29 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
US5573010A (en) * | 1991-11-18 | 1996-11-12 | Eckart Frimberger | Probe for medical procedures in cavities of the body |
US5591159A (en) * | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5591132A (en) * | 1995-01-25 | 1997-01-07 | Carrie; Len E. S. | Epidural catheter |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5593394A (en) * | 1995-01-24 | 1997-01-14 | Kanesaka; Nozomu | Shaft for a catheter system |
US5601586A (en) * | 1992-09-30 | 1997-02-11 | Linvatec Corporation | Variable angle rotating shaver |
US5601588A (en) * | 1994-09-29 | 1997-02-11 | Olympus Optical Co., Ltd. | Endoscopic puncture needle |
US5601537A (en) * | 1995-06-05 | 1997-02-11 | Frassica; James J. | Catheter system |
US5607405A (en) * | 1992-05-19 | 1997-03-04 | Decker; Rand A. | Surgical insertion device and method |
US5620414A (en) * | 1992-06-30 | 1997-04-15 | Campbell, Jr.; Robert M. | Apparatus and method for effecting surgical incision through use of a fluid jet |
US5672174A (en) * | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5697882A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5700259A (en) * | 1990-09-24 | 1997-12-23 | Plc Medical Systems, Inc. | Thoracoscopic transmyocardial revascularization handpiece assembly |
US5713894A (en) * | 1996-02-27 | 1998-02-03 | Murphy-Chutorian; Douglas | Combined mechanical/optical system for transmyocardial revascularization |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5766164A (en) * | 1996-07-03 | 1998-06-16 | Eclipse Surgical Technologies, Inc. | Contiguous, branched transmyocardial revascularization (TMR) channel, method and device |
US5769843A (en) * | 1996-02-20 | 1998-06-23 | Cormedica | Percutaneous endomyocardial revascularization |
US5788713A (en) * | 1994-07-22 | 1998-08-04 | University Of Washington | Method and apparatus for stereotactic implantation |
US5792116A (en) * | 1995-05-17 | 1998-08-11 | Scimed Life Systems, Inc. | Catheter having geometrically shaped surface and method of manufacture |
US5797870A (en) * | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5807388A (en) * | 1994-05-25 | 1998-09-15 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5810836A (en) * | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
US5827203A (en) * | 1997-04-21 | 1998-10-27 | Nita; Henry | Ultrasound system and method for myocardial revascularization |
US5840059A (en) * | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
US5853409A (en) * | 1994-06-27 | 1998-12-29 | E.P. Technologies, Inc. | Systems and apparatus for sensing temperature in body tissue |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5873366A (en) * | 1996-11-07 | 1999-02-23 | Chim; Nicholas | Method for transmyocardial revascularization |
US5882347A (en) * | 1996-09-09 | 1999-03-16 | Cordis Europa, N.V. | Catheter with internal stiffening ridges |
US5902289A (en) * | 1994-07-08 | 1999-05-11 | Daig Corporation | Precurved guiding introducer system for treatment of atrial arrhythmia |
US5911729A (en) * | 1997-08-13 | 1999-06-15 | United States Surgical Corporation | Electrocautery coring using solid needle |
US5913853A (en) * | 1997-01-30 | 1999-06-22 | Cardiodyne, Inc. | Laser energy device and procedure for forming a channel within tissue |
US5921982A (en) * | 1993-07-30 | 1999-07-13 | Lesh; Michael D. | Systems and methods for ablating body tissue |
US5931848A (en) * | 1996-12-02 | 1999-08-03 | Angiotrax, Inc. | Methods for transluminally performing surgery |
US5944716A (en) * | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5947989A (en) * | 1996-12-12 | 1999-09-07 | United States Surgical Corporation | Method and apparatus for transmyocardial revascularization |
US5964754A (en) * | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5984908A (en) * | 1997-04-10 | 1999-11-16 | Chase Medical Inc | Venous return catheter having integral support member |
US6004280A (en) * | 1997-08-05 | 1999-12-21 | Cordis Corporation | Guiding sheath having three-dimensional distal end |
US6042581A (en) * | 1996-11-08 | 2000-03-28 | Thomas J. Fogarty | Transvascular TMR device and method |
US6045565A (en) * | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6053924A (en) * | 1996-11-07 | 2000-04-25 | Hussein; Hany | Device and method for trans myocardial revascularization |
US6056742A (en) * | 1997-02-03 | 2000-05-02 | Eclipse Surgical Technologies, Inc. | Revascularization with laser outputs |
US6056743A (en) * | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US6066126A (en) * | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6068622A (en) * | 1998-02-10 | 2000-05-30 | Medtronic Inc. | Single piece hub/strain relief that can be injection molded over a shaft |
US6129752A (en) * | 1996-05-24 | 2000-10-10 | Pacesetter Ab | Distal end device for an implantable electrical conductor and an electrical conductor equipped with such an end device |
US6203524B1 (en) * | 1997-02-10 | 2001-03-20 | Emx, Inc. | Surgical and pharmaceutical site access guide and methods |
US6228049B1 (en) * | 1996-02-09 | 2001-05-08 | Promex, Inc. | Surgical and pharmaceutical site access guide and methods |
US6425887B1 (en) * | 1998-12-09 | 2002-07-30 | Cook Incorporated | Multi-directional needle medical device |
US6595958B1 (en) * | 2000-08-08 | 2003-07-22 | Scimed Life Systems, Inc. | Tortuous path injection device and method |
US6893421B1 (en) * | 2000-08-08 | 2005-05-17 | Scimed Life Systems, Inc. | Catheter shaft assembly |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857057A (en) * | 1985-06-28 | 1989-08-15 | Olympus Optical Co., Ltd. | Endoscope treatment device |
US5486161A (en) * | 1993-02-02 | 1996-01-23 | Zomed International | Medical probe device and method |
US5651785A (en) | 1993-09-20 | 1997-07-29 | Abela Laser Systems, Inc. | Optical fiber catheter and method |
JP3394327B2 (en) | 1994-07-11 | 2003-04-07 | テルモ株式会社 | Tube inner surface treatment method |
US6152141A (en) | 1994-07-28 | 2000-11-28 | Heartport, Inc. | Method for delivery of therapeutic agents to the heart |
JP2001527429A (en) | 1995-05-10 | 2001-12-25 | イクリプス サージカル テクノロジーズ インコーポレイテッド | Apparatus and method for treating and diagnosing heart tissue |
US5762631A (en) | 1995-07-14 | 1998-06-09 | Localmed, Inc. | Method and system for reduced friction introduction of coaxial catheters |
DE19537084A1 (en) | 1995-10-05 | 1997-04-10 | Sievers Hans Hinrich Prof Dr M | Catheter for transmyocardial revasculation with guidable multi=ID main catheter |
IL118352A0 (en) | 1996-05-21 | 1996-09-12 | Sudai Amnon | Apparatus and methods for revascularization |
DE29609350U1 (en) | 1996-05-24 | 1996-08-29 | P Osypka Mbh Ges Fuer Medizint | Device for perforating the heart wall |
EP0949910A4 (en) | 1996-08-08 | 2001-01-17 | Localmed Inc | Transmural drug delivery method and apparatus |
JP2002500523A (en) * | 1996-10-17 | 2002-01-08 | エチコン・エンド―サージエリー・インコーポレーテツド | Method and apparatus for improving blood flow to a patient's heart |
US6030377A (en) | 1996-10-21 | 2000-02-29 | Plc Medical Systems, Inc. | Percutaneous transmyocardial revascularization marking system |
WO1998018391A1 (en) | 1996-10-30 | 1998-05-07 | Ekos Corporation | Intraluminal wall drug delivery device |
US5845646A (en) | 1996-11-05 | 1998-12-08 | Lemelson; Jerome | System and method for treating select tissue in a living being |
AU5905098A (en) | 1996-12-23 | 1998-07-17 | Advanced Coronary Intervention | Radio frequency transmyocardial revascularization |
US5968059A (en) | 1997-03-06 | 1999-10-19 | Scimed Life Systems, Inc. | Transmyocardial revascularization catheter and method |
US6086582A (en) | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
JP2001506172A (en) | 1997-07-22 | 2001-05-15 | イーメッド コーポレイション | Needle for iontophoretic delivery of active substance |
JP2002512552A (en) | 1997-07-22 | 2002-04-23 | イーメッド コーポレイション | Delivery of drugs into heart tissue by iontophoresis. |
US6179809B1 (en) * | 1997-09-24 | 2001-01-30 | Eclipse Surgical Technologies, Inc. | Drug delivery catheter with tip alignment |
JP4535468B2 (en) | 1998-02-05 | 2010-09-01 | バイオセンス・ウエブスター・インコーポレーテツド | Intracardiac drug delivery |
US5997509A (en) | 1998-03-06 | 1999-12-07 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery device and method |
WO2000015146A1 (en) | 1998-09-10 | 2000-03-23 | Percardia, Inc. | Transmyocardial shunt for left ventricular revascularization |
US6312402B1 (en) | 1998-09-24 | 2001-11-06 | Ekos Corporation | Ultrasound catheter for improving blood flow to the heart |
US6217554B1 (en) | 1999-02-12 | 2001-04-17 | Pharmaspec Corporation | Methods and apparatus for delivering substances into extravascular tissue |
-
2000
- 2000-08-08 US US09/635,083 patent/US6893421B1/en not_active Expired - Lifetime
-
2001
- 2001-08-06 DE DE60109626T patent/DE60109626T2/en not_active Expired - Lifetime
- 2001-08-06 JP JP2002517139A patent/JP2004505689A/en active Pending
- 2001-08-06 WO PCT/US2001/024585 patent/WO2002011808A2/en active IP Right Grant
- 2001-08-06 CA CA002418149A patent/CA2418149A1/en not_active Abandoned
- 2001-08-06 AU AU2001279204A patent/AU2001279204A1/en not_active Abandoned
- 2001-08-06 EP EP01957461A patent/EP1311316B1/en not_active Expired - Lifetime
-
2004
- 2004-11-03 US US10/979,233 patent/US20050065474A1/en not_active Abandoned
Patent Citations (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578061A (en) * | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
US4658817A (en) * | 1985-04-01 | 1987-04-21 | Children's Hospital Medical Center | Method and apparatus for transmyocardial revascularization using a laser |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
US4790311A (en) * | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
US5267982A (en) * | 1988-04-29 | 1993-12-07 | C. R. Bard, Inc. | Variable shaped catheter system and method for catheterization |
US4896671A (en) * | 1988-08-01 | 1990-01-30 | C. R. Bard, Inc. | Catheter with contoured ablation electrode |
US4940458A (en) * | 1989-02-02 | 1990-07-10 | Cohn Arnold K | Epidural needle placement system |
US4973321A (en) * | 1989-03-17 | 1990-11-27 | Michelson Gary K | Cannula for an arthroscope |
US5047026A (en) * | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
US5364393A (en) * | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
US5700259A (en) * | 1990-09-24 | 1997-12-23 | Plc Medical Systems, Inc. | Thoracoscopic transmyocardial revascularization handpiece assembly |
US5221269A (en) * | 1990-10-15 | 1993-06-22 | Cook Incorporated | Guide for localizing a nonpalpable breast lesion |
US5093877A (en) * | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5380316A (en) * | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5925033A (en) * | 1990-12-18 | 1999-07-20 | Cardiogenesis Corporation | Method for intra-operative myocardial revascularization |
US5573010A (en) * | 1991-11-18 | 1996-11-12 | Eckart Frimberger | Probe for medical procedures in cavities of the body |
US5873855A (en) * | 1992-01-07 | 1999-02-23 | Arthrocare Corporation | Systems and methods for electrosurgical myocardial revascularization |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5697882A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5358485A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5607405A (en) * | 1992-05-19 | 1997-03-04 | Decker; Rand A. | Surgical insertion device and method |
US5620414A (en) * | 1992-06-30 | 1997-04-15 | Campbell, Jr.; Robert M. | Apparatus and method for effecting surgical incision through use of a fluid jet |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5601586A (en) * | 1992-09-30 | 1997-02-11 | Linvatec Corporation | Variable angle rotating shaver |
US5354279A (en) * | 1992-10-21 | 1994-10-11 | Bavaria Medizin Technologie Gmbh | Plural needle injection catheter |
US5287861A (en) * | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5261889A (en) * | 1992-11-24 | 1993-11-16 | Boston Scientific Corporation | Injection therapy catheter |
US5353800A (en) * | 1992-12-11 | 1994-10-11 | Medtronic, Inc. | Implantable pressure sensor lead |
US5522815A (en) * | 1993-03-29 | 1996-06-04 | Durgin, Jr.; Russell F. | Integrated catheter for diverse in situ tissue therapy |
US5403311A (en) * | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5921982A (en) * | 1993-07-30 | 1999-07-13 | Lesh; Michael D. | Systems and methods for ablating body tissue |
US5405376A (en) * | 1993-08-27 | 1995-04-11 | Medtronic, Inc. | Method and apparatus for ablation |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5569462A (en) * | 1993-09-24 | 1996-10-29 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
US5464395A (en) * | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5507731A (en) * | 1994-05-17 | 1996-04-16 | Cordis Corporation | Rapid exchange segmented catheter |
US5807388A (en) * | 1994-05-25 | 1998-09-15 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5853409A (en) * | 1994-06-27 | 1998-12-29 | E.P. Technologies, Inc. | Systems and apparatus for sensing temperature in body tissue |
US5902289A (en) * | 1994-07-08 | 1999-05-11 | Daig Corporation | Precurved guiding introducer system for treatment of atrial arrhythmia |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5788713A (en) * | 1994-07-22 | 1998-08-04 | University Of Washington | Method and apparatus for stereotactic implantation |
US5480389A (en) * | 1994-08-09 | 1996-01-02 | Becton, Dickinson And Company | Method and apparatus for adjusting the length of a combined spinal-epidural needle |
US5601588A (en) * | 1994-09-29 | 1997-02-11 | Olympus Optical Co., Ltd. | Endoscopic puncture needle |
US5591159A (en) * | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5593394A (en) * | 1995-01-24 | 1997-01-14 | Kanesaka; Nozomu | Shaft for a catheter system |
US5591132A (en) * | 1995-01-25 | 1997-01-07 | Carrie; Len E. S. | Epidural catheter |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
US5792116A (en) * | 1995-05-17 | 1998-08-11 | Scimed Life Systems, Inc. | Catheter having geometrically shaped surface and method of manufacture |
US5601537A (en) * | 1995-06-05 | 1997-02-11 | Frassica; James J. | Catheter system |
US5797870A (en) * | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5840059A (en) * | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
US5672174A (en) * | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US6228049B1 (en) * | 1996-02-09 | 2001-05-08 | Promex, Inc. | Surgical and pharmaceutical site access guide and methods |
US5769843A (en) * | 1996-02-20 | 1998-06-23 | Cormedica | Percutaneous endomyocardial revascularization |
US5713894A (en) * | 1996-02-27 | 1998-02-03 | Murphy-Chutorian; Douglas | Combined mechanical/optical system for transmyocardial revascularization |
US5810836A (en) * | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US6129752A (en) * | 1996-05-24 | 2000-10-10 | Pacesetter Ab | Distal end device for an implantable electrical conductor and an electrical conductor equipped with such an end device |
US5964754A (en) * | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5766164A (en) * | 1996-07-03 | 1998-06-16 | Eclipse Surgical Technologies, Inc. | Contiguous, branched transmyocardial revascularization (TMR) channel, method and device |
US5882347A (en) * | 1996-09-09 | 1999-03-16 | Cordis Europa, N.V. | Catheter with internal stiffening ridges |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US6053924A (en) * | 1996-11-07 | 2000-04-25 | Hussein; Hany | Device and method for trans myocardial revascularization |
US5873366A (en) * | 1996-11-07 | 1999-02-23 | Chim; Nicholas | Method for transmyocardial revascularization |
US6053911A (en) * | 1996-11-08 | 2000-04-25 | Thomas J. Fogarty | Transvascular TMR device and method |
US6042581A (en) * | 1996-11-08 | 2000-03-28 | Thomas J. Fogarty | Transvascular TMR device and method |
US5931848A (en) * | 1996-12-02 | 1999-08-03 | Angiotrax, Inc. | Methods for transluminally performing surgery |
US5944716A (en) * | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5947989A (en) * | 1996-12-12 | 1999-09-07 | United States Surgical Corporation | Method and apparatus for transmyocardial revascularization |
US5913853A (en) * | 1997-01-30 | 1999-06-22 | Cardiodyne, Inc. | Laser energy device and procedure for forming a channel within tissue |
US6056742A (en) * | 1997-02-03 | 2000-05-02 | Eclipse Surgical Technologies, Inc. | Revascularization with laser outputs |
US6203524B1 (en) * | 1997-02-10 | 2001-03-20 | Emx, Inc. | Surgical and pharmaceutical site access guide and methods |
US5984908A (en) * | 1997-04-10 | 1999-11-16 | Chase Medical Inc | Venous return catheter having integral support member |
US5827203A (en) * | 1997-04-21 | 1998-10-27 | Nita; Henry | Ultrasound system and method for myocardial revascularization |
US6004280A (en) * | 1997-08-05 | 1999-12-21 | Cordis Corporation | Guiding sheath having three-dimensional distal end |
US5911729A (en) * | 1997-08-13 | 1999-06-15 | United States Surgical Corporation | Electrocautery coring using solid needle |
US6045565A (en) * | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6056743A (en) * | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US6066126A (en) * | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6068622A (en) * | 1998-02-10 | 2000-05-30 | Medtronic Inc. | Single piece hub/strain relief that can be injection molded over a shaft |
US6425887B1 (en) * | 1998-12-09 | 2002-07-30 | Cook Incorporated | Multi-directional needle medical device |
US6595958B1 (en) * | 2000-08-08 | 2003-07-22 | Scimed Life Systems, Inc. | Tortuous path injection device and method |
US6893421B1 (en) * | 2000-08-08 | 2005-05-17 | Scimed Life Systems, Inc. | Catheter shaft assembly |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060015168A1 (en) * | 2004-07-13 | 2006-01-19 | Scimed Life Systems, Inc. | Catheter |
US8500785B2 (en) | 2004-07-13 | 2013-08-06 | Boston Scientific Scimed, Inc. | Catheter |
US8109983B2 (en) | 2004-08-06 | 2012-02-07 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
US20050049609A1 (en) * | 2004-08-06 | 2005-03-03 | Scimed Life Systems, Inc. | Medical device delivery systems |
US20060047246A1 (en) * | 2004-08-24 | 2006-03-02 | 3Fi Products Llc | Catheter with retractable needle, and methods of use and manufacture |
US20060095110A1 (en) * | 2004-10-29 | 2006-05-04 | Scimed Life Systems, Inc. | Implantable medical endoprosthesis delivery systems and related components |
US7666217B2 (en) | 2004-10-29 | 2010-02-23 | Boston Scientific Scimed, Inc. | Implantable medical endoprosthesis delivery systems and related components |
EP1731190A1 (en) * | 2005-05-31 | 2006-12-13 | BIOENGINEERING LABORATORIES S.p.A. | Assembly of a vascular drive device and a removable stiffening means |
US7803130B2 (en) | 2006-01-09 | 2010-09-28 | Vance Products Inc. | Deflectable tip access sheath |
US9186055B2 (en) * | 2006-02-03 | 2015-11-17 | Cannuflow, Inc. | Anti-extravasation sheath |
US20120157972A1 (en) * | 2006-02-03 | 2012-06-21 | Cannuflow, Inc. | Anti-Extravasation Sheath |
US20080171985A1 (en) * | 2006-10-16 | 2008-07-17 | Y.K.K. Saglik Hizmetleri Limited Sirketi | Flexible and Rigid Catheter Resector Balloon |
US8758231B2 (en) | 2009-05-14 | 2014-06-24 | Cook Medical Technologies Llc | Access sheath with active deflection |
US20140031686A1 (en) * | 2009-05-29 | 2014-01-30 | Boston Scientific SclMed, Inc. | Systems and methods for making and using image-guided intravascular and endocardial therapy systems |
US8876722B2 (en) * | 2009-07-23 | 2014-11-04 | Acist Medical Systems, Inc. | Endoventricular injection catheter system with integrated echocardiographic capabilities |
US20110021911A1 (en) * | 2009-07-23 | 2011-01-27 | Silicon Valley Medical Instruments, Inc. | Endoventricular injection catheter system with integrated echocardiographic capabilities |
US9610425B2 (en) | 2009-07-23 | 2017-04-04 | Acist Medical Systems, Inc. | Endoventricular injection catheter system with integrated echocardiographic capabilities |
WO2017079325A3 (en) * | 2015-11-03 | 2018-03-01 | Clph, Llc | Injection devices and systems and methods for using them |
US10500332B2 (en) | 2015-11-03 | 2019-12-10 | Clph, Llc | Injection devices and systems and methods for using them |
WO2019067790A3 (en) * | 2017-09-27 | 2019-05-23 | Clph, Llc | Injection devices and systems and methods for using them |
CN111182933A (en) * | 2017-09-27 | 2020-05-19 | Clph有限责任公司 | Injection device and system and method of use thereof |
WO2019066847A1 (en) * | 2017-09-28 | 2019-04-04 | C.R. Bard, Inc. | Catheter with movable indicator |
CN111148475A (en) * | 2017-09-28 | 2020-05-12 | 巴德股份有限公司 | Catheter with movable indicator |
US11369772B2 (en) | 2017-09-28 | 2022-06-28 | C.R. Bard, Inc. | Catheter with movable indicator |
Also Published As
Publication number | Publication date |
---|---|
EP1311316A2 (en) | 2003-05-21 |
WO2002011808A3 (en) | 2002-04-11 |
CA2418149A1 (en) | 2002-02-14 |
WO2002011808A2 (en) | 2002-02-14 |
DE60109626D1 (en) | 2005-04-28 |
US6893421B1 (en) | 2005-05-17 |
EP1311316B1 (en) | 2005-03-23 |
JP2004505689A (en) | 2004-02-26 |
AU2001279204A1 (en) | 2002-02-18 |
DE60109626T2 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6893421B1 (en) | Catheter shaft assembly | |
US7399294B2 (en) | Controlled depth injection device | |
EP1307257B1 (en) | Tortuouse path injection device and method | |
US6217575B1 (en) | PMR catheter | |
CA2373034C (en) | Injection array apparatus and method | |
US6322548B1 (en) | Delivery catheter system for heart chamber | |
US5538504A (en) | Intra-extravascular drug delivery catheter and method | |
EP1349605B1 (en) | Intra-pericardial drug delivery device for angiogenesis | |
EP0908194A2 (en) | Drug delivery catheter with tip alignment | |
US20060095015A1 (en) | Venous insufficiency treatment method | |
US20090118673A1 (en) | Needle injection catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SCIMED LIFE SYSTEMS, INC.,MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LARSON, SCOTT;CRANK, JUSTIN;HAWK, MATTHEW;AND OTHERS;SIGNING DATES FROM 20000530 TO 20000605;REEL/FRAME:024624/0627 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:024624/0693 Effective date: 20041222 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |